22-23 July 2016 - Phoenicia Intercontinental Beirut

Sanofi Aventis Liban SAL - Corniche El Nahr, Pierre Gemayel street, Holcom building, 2nd floor. Beirut, Lebanon. P.O Box: 110697, Phone: +961 1 440 220, Fax: +961 1 562 264

"This is a personal invitation. We would like to remind you that according to the MEA code of pharmaceutical promotional practices, inclusion of a health care professional's spouse or other guest to any promotional, professional or scientific event is not appropriate.”

SALE

V.O

NC

.16.

07.0

151 CME

CREDITS

11:10 – 11:25 Discussion ( Panelists & Speakers )

11:25 -12:25 Plenary III: Advanced Prostate Cancer: Guidelines and New Paradigms Panelists: Mervat Mahrous MD, Oncology KSA Mohamad Bulbul MD, Urology LB Hesham El Ghazaly MD, Oncology Egypt

11:25 – 11:45 The Role of Modern Imaging in Monitoring Patients With Advanced Prostate Cancer Elie Nemr MD , Urology LB

11:45 – 12:15 Paradigm Change in Prostate Cancer Management Protocols - Christopher Sweeney, MD

12:15 – 12:25 Discussion ( Panelists & Speakers )

12:25- 13:30 Plenary IV: Sequencing Therapies in mCRPC Chairman : Georges Chahine MD, Oncology LB Panelists : Mohamad Abdullah MD, Oncology Egypt Amin Al Tigani MD, Oncology KSA 12:25 – 13:00 Best Sequencing of Current Therapies in mCRPC - Christopher Sweeney, MD

13:00 – 13:10 Quality of Life in Advanced Prostate Cancer - Georges Chahine MD, Oncology LB

13:10 – 13:30 Discussion ( Panelists & Speakers )

13:30 – 14:30 Lunch

09:00-09:10 Welcome Note & Opening - Raghid Khoury MD, Urology - President of Lebanese Urology Society 09:10 – 10:10 Plenary I: The Heterogeneity of Prostate Cancer Panelists: Joseph Makdessi MD, Oncology LB Abdullah Al Sharm MD, Oncology KSA Fouad Abotaleb MD, Oncology Egypt

09:10 – 09:30 Understanding the Heterogeneity of Prostate Cancer - Christopher Sweeney, MD 09:30 – 09:50 Personalized Medicine in Prostate Cancer - Marwan Ghosn MD, Oncology LB 09:50 – 10:10 Discussion ( Panelists & Speakers )

10:10 – 10:25 Coffee Break 10:25 – 11:25 Plenary II: Emerging Biomarkers in Prostate Cancer Panelists: Nabil Chamseddine MD, Oncology LB Muhammad Azfar MD, Oncology KSA Mohamad Abdelkader MD, Oncology Egypt

10:25 – 10:40 The Prognostic Role of Neutrophil Lymphocyte Ratio in Prostate Cancer - Joseph Kattan MD, Oncology LB

10:40 – 10:55 Biomarkers Development in Prostate Cancer - Jawaher Ansari MD , Oncology KSA

10:55 – 11:10 Challenges in Our Practice - Fadi Farhat MD , Oncology LB

Sanofi 2 Middle East Solid Tumors Meeting22-23 July 2016- Phoenicia Intercontinental Beirut

nd

14:30 – 15:30 Plenary V: Clinical Cases Presentation and Discussion ( Voting Session ) Panelists : Georges Kassaf MD , Urology LB Abdullah El Sharm MD, Oncology KSA Ramy Ghaly MD, Oncology Egypt

14:30 – 14:40 Case 1 : Pierre Sarkis MD, Urology LB

14:40 – 14:50 Case 2 : Ali Jubran MD, Oncology KSA

14:50 – 15:00 Case 3 : Salem Eid, MD Oncology Egypt

15:00 – 15:30 Discussion ( Panelists & Speakers )

15:30 – 15:45 Coffee Break

15:45 – 17:00 Plenary VI: MDT Approach : Experience Sharing Panelists : Raghid Khoury MD, Urology LB Ziad Salem MD, Oncology LB Mohamad Moussa MD, Urology LB 15:45 – 16:00 Evaluation of Multidisciplinary Team Meeting in Uro-Oncology: Notre Dame des Secours University Hospital Experience Raghid Khoury MD, Urology LB

16:00 – 16:15 Case 1 : Khaled Ibrahim MD, Oncology LB

16:15 – 16:30 Case 2 : Khaled Sayed MD, Urology LB 16:30 – 17:00 Discussion ( Panelists & Speakers)

New Horizons for the Management of Metastatic Castration Resistant Prostate Cancer : Optimizing Treatment Outcomes

Sanofi 2 Middle East Solid Tumors Meeting22-23 July 2016- Phoenicia Intercontinental Beirut

nd Sanofi 2 Middle East Solid Tumors Meeting22-23 July 2016- Phoenicia Intercontinental Beirut

nd